Welblu - Happy minds

 

Emerging Technology – Drug/device combination – EMA guidelines

July 26, 2022by Focelite0

This guideline describes the information that should be presented in the Quality part of a marketing authorisation dossier for a medicinal product when it is used with a medical device, or device part, and submitted in accordance with Directive 2001/83/EC and/or Regulation (EC) 726/2004. This guideline focuses on product-specific quality aspects of a medical device, or device part, that may have an impact on the quality, safety and/or efficacy (and hence overall benefit/risk determination) of a medicinal product.

For more details, please click on the link

Focelite

Leave a Reply

Your email address will not be published. Required fields are marked *